ES2967443T3 - Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células - Google Patents

Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células Download PDF

Info

Publication number
ES2967443T3
ES2967443T3 ES17824931T ES17824931T ES2967443T3 ES 2967443 T3 ES2967443 T3 ES 2967443T3 ES 17824931 T ES17824931 T ES 17824931T ES 17824931 T ES17824931 T ES 17824931T ES 2967443 T3 ES2967443 T3 ES 2967443T3
Authority
ES
Spain
Prior art keywords
fragments
multiparametric
tumor
genome
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17824931T
Other languages
English (en)
Spanish (es)
Inventor
Diana Abdueva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guardant Health Inc
Original Assignee
Guardant Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guardant Health Inc filed Critical Guardant Health Inc
Application granted granted Critical
Publication of ES2967443T3 publication Critical patent/ES2967443T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES17824931T 2016-07-06 2017-07-06 Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células Active ES2967443T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662359151P 2016-07-06 2016-07-06
US201662420167P 2016-11-10 2016-11-10
US201662437172P 2016-12-21 2016-12-21
US201762489399P 2017-04-24 2017-04-24
PCT/US2017/040986 WO2018009723A1 (en) 2016-07-06 2017-07-06 Methods for fragmentome profiling of cell-free nucleic acids

Publications (1)

Publication Number Publication Date
ES2967443T3 true ES2967443T3 (es) 2024-04-30

Family

ID=60913158

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17824931T Active ES2967443T3 (es) 2016-07-06 2017-07-06 Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células

Country Status (12)

Country Link
US (1) US20260204345A9 (enExample)
EP (2) EP4322168A3 (enExample)
JP (3) JP7448310B2 (enExample)
KR (1) KR102610098B1 (enExample)
CN (1) CN109689891B (enExample)
AU (1) AU2017292854B2 (enExample)
BR (1) BR112019000296A2 (enExample)
CA (1) CA3030038A1 (enExample)
ES (1) ES2967443T3 (enExample)
MX (1) MX2019000037A (enExample)
SG (1) SG11201811556RA (enExample)
WO (1) WO2018009723A1 (enExample)

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2854058A3 (en) 2010-05-18 2015-10-28 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
AU2011348100B2 (en) 2010-12-22 2016-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
EP3246416B1 (en) 2011-04-15 2024-06-05 The Johns Hopkins University Safe sequencing system
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
WO2014070462A1 (en) 2012-10-29 2014-05-08 The Johns Hopkins University Papanicolaou test for ovarian and endometrial cancers
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP4428863A3 (en) 2015-05-11 2024-12-11 Natera, Inc. Methods and compositions for determining ploidy
US10453556B2 (en) 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
KR102326769B1 (ko) 2016-03-25 2021-11-17 카리우스, 인코포레이티드 합성 핵산 스파이크-인
JP7280044B2 (ja) 2016-04-15 2023-05-23 ナテラ， インコーポレイテッド 肺癌の検出方法
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
IL302912A (en) 2016-12-22 2023-07-01 Guardant Health Inc Methods and systems for analyzing nucleic acid molecules
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
EP3635134A4 (en) * 2017-06-09 2021-03-03 Bellwether Bio, Inc. DIAGNOSTIC CANCER OR OTHER PHYSIOLOGICAL CONDITIONS USING CIRCULATING NUCLEIC ACID FRAGMENT SENTINEL END POINTS
JP7181900B2 (ja) * 2017-06-15 2022-12-01 ノボ・ノルデイスク・エー／エス 患者プロファイルに基づくインスリン滴定アルゴリズム
CN110741438B (zh) 2017-06-15 2023-12-29 诺和诺德股份有限公司 具有适应性靶葡萄糖水平的基础滴定
WO2019016353A1 (en) * 2017-07-21 2019-01-24 F. Hoffmann-La Roche Ag CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE
KR20250047324A (ko) 2017-08-07 2025-04-03 더 존스 홉킨스 유니버시티 암을 평가하고 치료하기 위한 방법 및 재료
WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. SAMPLE EXTRACTION METHODS AND SYSTEMS
US11728007B2 (en) * 2017-11-30 2023-08-15 Grail, Llc Methods and systems for analyzing nucleic acid sequences using mappability analysis and de novo sequence assembly
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3737773B1 (en) 2018-01-12 2023-04-12 Natera, Inc. Novel primers and uses thereof
EP3743518A4 (en) * 2018-01-24 2021-09-29 Freenome Holdings, Inc. METHODS AND SYSTEMS FOR DETECTING ANOMALY IN PATTERNS OF NUCLEIC ACIDS
US20210002728A1 (en) * 2018-02-27 2021-01-07 Cornell University Systems and methods for detection of residual disease
IL276891B2 (en) 2018-02-27 2025-05-01 Univ Cornell Highly sensitive detection of circulating DNA using genome-wide integration
US11767562B2 (en) 2018-03-08 2023-09-26 St. John's University Circulating serum cell-free DNA biomarkers and methods
US12626780B2 (en) 2018-03-13 2026-05-12 Grail, Inc. Method and system for selecting, managing, and analyzing data of high dimensionality
WO2019178563A1 (en) * 2018-03-15 2019-09-19 The Board Of Trustees Of Leland Stanford Junior University Methods using nucleic acid signals for revealing biological attributes
CA3095030A1 (en) * 2018-03-30 2019-10-03 Juno Diagnostics, Inc. Deep learning-based methods, devices, and systems for prenatal testing
EP3776555A2 (en) * 2018-04-13 2021-02-17 Grail, Inc. Multi-assay prediction model for cancer detection
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
CN112888459B (zh) 2018-06-01 2023-05-23 格里尔公司 卷积神经网络系统及数据分类方法
WO2020006369A1 (en) * 2018-06-29 2020-01-02 Guardant Health, Inc. Methods and systems for analysis of ctcf binding regions in cell-free dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US20200075124A1 (en) * 2018-09-04 2020-03-05 Guardant Health, Inc. Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
EP3815005A4 (en) * 2018-10-08 2022-03-30 Freenome Holdings, Inc. Transcription factor profiling
GB201818159D0 (en) * 2018-11-07 2018-12-19 Cancer Research Tech Ltd Enhanced detection of target dna by fragment size analysis
WO2020106987A1 (en) * 2018-11-21 2020-05-28 Karius, Inc. Detection and prediction of infectious disease
EP4700161A3 (en) 2018-11-21 2026-03-11 Karius, Inc. Direct-to-library methods, systems, and compositions
US10468141B1 (en) * 2018-11-28 2019-11-05 Asia Genomics Pte. Ltd. Ancestry-specific genetic risk scores
US11581062B2 (en) 2018-12-10 2023-02-14 Grail, Llc Systems and methods for classifying patients with respect to multiple cancer classes
CN113366122B (zh) * 2018-12-19 2024-01-12 香港中文大学 游离dna末端特征
CN113195741A (zh) * 2018-12-21 2021-07-30 豪夫迈·罗氏有限公司 从循环核酸中鉴定全基因组序列数据中的全局序列特征
US20200219587A1 (en) * 2018-12-21 2020-07-09 Grail, Inc. Systems and methods for using fragment lengths as a predictor of cancer
WO2020150258A1 (en) * 2019-01-15 2020-07-23 Luminist, Inc. Methods and systems for detecting liver disease
KR20260023068A (ko) * 2019-01-24 2026-02-20 일루미나, 인코포레이티드 장기 건강 및 질환을 모니터링하기 위한 방법 및 시스템
EP4567131A3 (en) 2019-01-31 2025-09-03 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
US11475978B2 (en) 2019-02-12 2022-10-18 Tempus Labs, Inc. Detection of human leukocyte antigen loss of heterozygosity
AU2020221847B2 (en) 2019-02-12 2026-04-02 Tempus Ai, Inc. Detection of Human Leukocyte Antigen loss of heterozygosity
WO2020172435A1 (en) * 2019-02-20 2020-08-27 The Regents Of The University Of California System and method for tissue classification using quantitative image analysis of serial scans
WO2020176659A1 (en) * 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
EP3956466A1 (en) * 2019-04-15 2022-02-23 Natera, Inc. Improved liquid biopsy using size selection
US12497662B2 (en) 2019-04-16 2025-12-16 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
EP4425506A3 (en) * 2019-05-22 2024-12-04 Grail, Inc. Systems and methods for determining whether a subject has a cancer condition using transfer learning
EP3976822A1 (en) 2019-05-31 2022-04-06 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
WO2021007462A1 (en) * 2019-07-09 2021-01-14 The Translational Genomics Research Institute METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA
WO2021016441A1 (en) * 2019-07-23 2021-01-28 Grail, Inc. Systems and methods for determining tumor fraction
EP4018003A1 (en) * 2019-08-28 2022-06-29 Grail, LLC Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
CN110706749B (zh) * 2019-09-10 2022-06-10 至本医疗科技（上海）有限公司 一种基于组织器官分化层次关系的癌症类型预测系统和方法
EP4041919A1 (en) 2019-09-30 2022-08-17 Guardant Health, Inc. Compositions and methods for analyzing cell-free dna in methylation partitioning assays
WO2021072275A1 (en) * 2019-10-11 2021-04-15 Guardant Health, Inc. Use of cell free bacterial nucleic acids for detection of cancer
ES3031713T3 (en) 2019-11-26 2025-07-10 Guardant Health Inc Methods, compositions and systems for improving the binding of methylated polynucleotides
WO2021107676A1 (ko) * 2019-11-29 2021-06-03 주식회사 녹십자지놈 인공지능 기반 염색체 이상 검출 방법
EP4077735A4 (en) * 2019-12-20 2024-01-24 AccuraGen Holdings Limited METHOD AND SYSTEMS FOR DETECTING DISEASES
EP4081655B1 (en) * 2019-12-24 2026-03-18 Vib Vzw Disease detection in liquid biopsies
WO2021163546A1 (en) 2020-02-14 2021-08-19 The Johns Hopkins University Methods and materials for assessing nucleic acids
JP2023516633A (ja) * 2020-02-28 2023-04-20 グレイル リミテッド ライアビリティ カンパニー メチル化シークエンシングデータを使用したバリアントをコールするためのシステムおよび方法
WO2021222828A1 (en) 2020-04-30 2021-11-04 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
WO2021236993A1 (en) 2020-05-22 2021-11-25 Bloodq, Inc. Methods for characterizing cell-free nucleic acid fragments
AU2021291586B2 (en) * 2020-06-19 2024-02-15 University Health Network Multimodal analysis of circulating tumor nucleic acid molecules
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
ES3018032T3 (en) 2020-07-30 2025-05-14 Guardant Health Inc Methods for isolating cell-free dna
WO2022040163A1 (en) * 2020-08-18 2022-02-24 Delfi Diagnostics, Inc. Methods and systems for cell-free dna fragment size densities to assess cancer
WO2022046947A1 (en) 2020-08-25 2022-03-03 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
WO2022061080A1 (en) * 2020-09-17 2022-03-24 The Regents Of The University Of Colorado, A Body Corporate Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
JP2023544720A (ja) 2020-09-30 2023-10-25 ガーダント ヘルス， インコーポレイテッド Ｄｎａメチル化分配アッセイのシグナル対ノイズ比を改善するための方法およびシステム
WO2022087309A1 (en) 2020-10-23 2022-04-28 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and base conversion
EP4251765A1 (en) 2020-11-30 2023-10-04 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
CN114634982A (zh) * 2020-12-15 2022-06-17 广州市基准医疗有限责任公司 一种检测多核苷酸变异的方法
EP4015650A1 (en) * 2020-12-18 2022-06-22 Nipd Genetics Biotech Limited Methods for classifying a sample into clinically relevant categories
EP4267757A1 (en) 2020-12-23 2023-11-01 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
WO2022174109A1 (en) 2021-02-12 2022-08-18 Guardant Health, Inc. Methods and compositions for detecting nucleic acid variants
WO2022204730A1 (en) 2021-03-25 2022-09-29 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
WO2022216981A1 (en) * 2021-04-08 2022-10-13 Delfi Diagnostics, Inc. Method of detecting cancer using genome-wide cfdna fragmentation profiles
AU2022255198A1 (en) * 2021-04-08 2023-11-23 Fred Hutchinson Cancer Center Cell-free dna sequence data analysis method to examine nucleosome protection and chromatin accessibility
WO2022248844A1 (en) * 2021-05-24 2022-12-01 University Of Essex Enterprises Limited Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin
KR102927037B1 (ko) * 2021-05-28 2026-02-13 주식회사 지씨지놈 조직 특이적 조절 지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법
CN113838533B (zh) * 2021-08-17 2024-03-12 福建和瑞基因科技有限公司 一种癌症检测模型及其构建方法和试剂盒
CN118451200A (zh) * 2021-11-17 2024-08-06 小利兰·斯坦福大学托管委员会 用于从细胞游离dna推断基因表达和起源组织的系统和方法
KR102884871B1 (ko) * 2022-01-26 2025-11-11 권창혁 암 판별 장치 및 암 판별 방법
WO2023142311A1 (zh) * 2022-01-28 2023-08-03 深圳华大生命科学研究院 利用血浆游离dna预测孕期肿瘤组织来源的模型及其构建方法
US20230323473A1 (en) * 2022-03-03 2023-10-12 Helio Health Inc. Methods for multimodal epigenetic sequencing assays
EP4489011A4 (en) * 2022-03-03 2025-08-06 Lunit Inc METHOD AND APPARATUS FOR PATHOLOGICAL SLIDE IMAGE ANALYSIS
KR20250010581A (ko) * 2022-03-17 2025-01-21 델피 다이아그노스틱스, 인코포레이티드 단편화 프로파일을 사용한 암 모니터링 방법
JP2025513786A (ja) 2022-04-07 2025-04-30 ガーダント ヘルス， インコーポレイテッド 無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出
EP4532762A4 (en) * 2022-06-02 2026-06-03 Univ Leland Stanford Junior MONOMOLECULAR SEQUENCING AND ESTABLISHMENT OF THE CELLULAR DNA METHYLATION PROFILE
JP2025522763A (ja) 2022-06-30 2025-07-17 ガーダント ヘルス， インコーポレイテッド 異常にメチル化されたｄｎａの富化
US20240043935A1 (en) * 2022-07-29 2024-02-08 Centre For Novostics Limited Epigenetics analysis of cell-free dna
JP2025532196A (ja) 2022-09-27 2025-09-29 ガーダント ヘルス， インコーポレイテッド 免疫細胞ｄｎａを定量するための方法
CN115295074B (zh) * 2022-10-08 2022-12-16 南京世和基因生物技术股份有限公司 基因标志物在恶性肺结节筛查中的应用、筛查模型的构建方法和检测装置
WO2024112643A1 (en) * 2022-11-21 2024-05-30 Foundation Medicine, Inc. Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy
WO2024137880A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Methods involving methylation preserving amplification with error correction
WO2024138180A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Integrated targeted and whole genome somatic and dna methylation sequencing workflows
WO2024233502A1 (en) 2023-05-05 2024-11-14 Guardant Health, Inc. Cell-free dna blood-based test for cancer screening
CN116665784B (zh) * 2023-05-31 2025-12-30 华中农业大学 基于cfDNA全基因组测序数据识别染色质开放区域的方法、癌症预测模型及系统
CN121729505A (zh) * 2023-07-14 2026-03-24 纳特拉公司 测定循环肿瘤dna的方法
WO2025029475A1 (en) 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection
EP4758267A1 (en) 2023-08-11 2026-06-17 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
CN117230165A (zh) * 2023-09-01 2023-12-15 深圳湾实验室 一种无创产前检测胎儿染色体拷贝数异常的优化方法
EP4781415A1 (en) 2023-09-19 2026-07-29 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
WO2025076452A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
WO2025144650A1 (en) * 2023-12-28 2025-07-03 Genecentric Therapeutics, Inc. Method for using circulating tumor dna for cancer subtyping
WO2025160265A1 (en) * 2024-01-24 2025-07-31 Predicine, Inc. Systems and methods of fragmentomics analysis in cancer
WO2025207817A1 (en) 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
WO2025208044A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for cancer detection using molecular patterns
WO2025205006A1 (ja) * 2024-03-29 2025-10-02 ソニーグループ株式会社 分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット
WO2025235889A1 (en) 2024-05-10 2025-11-13 Guardant Health, Inc. Methods involving multiplexed pooled pcr
WO2025250544A1 (en) 2024-05-31 2025-12-04 Guardant Health, Inc. Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
WO2026043718A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods to monitor patients treated with a cancer vaccine
WO2026073140A1 (en) 2024-09-27 2026-04-02 Guardant Health, Inc. Framework to identify genomic regions indicative of one or more biological conditions
WO2026076332A1 (en) 2024-10-03 2026-04-09 Guardant Health, Inc. Methods involving multi-modal tumor variant identification and tracking of tumor molecules
WO2026090570A1 (en) 2024-10-24 2026-04-30 Guardant Health, Inc. Detecting the presence of a biological condition based on a nucleic acid sample data analysis
WO2026107204A1 (en) 2024-11-14 2026-05-21 Guardant Health, Inc. Methods for analyzing low-depth genome sequencing data to detect minimal residual disease
WO2026136560A1 (en) 2024-12-17 2026-06-25 Guardant Health, Inc. Methods for cfdna methylation data modeling using transformer neural network architecture
CN119905148B (zh) * 2024-12-30 2026-02-06 西藏自治区农牧科学院水产科学研究所 一种核间等位基因表达分析方法、装置及存储介质
WO2026165504A1 (en) 2025-01-31 2026-08-06 Guardant Health, Inc. Methods for detecting nucleic acids from cancer cells
CN120334449B (zh) * 2025-06-20 2025-09-05 陕西右任故里茯砖茶股份有限公司 基于液相色谱的茯砖茶中金花菌发酵检测方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102203606A (zh) 2008-10-30 2011-09-28 公共健康研究中心 生物标记物
CN101901345B (zh) * 2009-05-27 2013-02-27 复旦大学 一种差异蛋白质组学的分类方法
US11322224B2 (en) * 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2426217A1 (en) * 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
GB2485635B (en) * 2011-07-26 2012-11-28 Verinata Health Inc Method for determining the presence or absence of different aneuploidies in a sample
WO2013052913A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3736339B1 (en) 2012-02-16 2022-07-27 Oxford Nanopore Technologies plc Analysis of measurements of a polymer
AU2013232123B2 (en) * 2012-03-13 2014-10-30 The Chinese University Of Hong Kong Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis
CN103374518B (zh) * 2012-04-12 2018-03-27 维里纳塔健康公司 拷贝数变异的检测和分类
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
PL2893040T3 (pl) * 2012-09-04 2019-05-31 Guardant Health Inc Sposoby wykrywania rzadkich mutacji i wariantu liczby kopii
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20130309666A1 (en) * 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2980689T3 (es) * 2013-03-15 2024-10-02 Guardant Health Inc Métodos para la secuenciación de polinucleótidos libres de células
CN105722994B (zh) * 2013-06-17 2020-12-18 维里纳塔健康公司 用于确定性染色体中的拷贝数变异的方法
WO2015048535A1 (en) * 2013-09-27 2015-04-02 Natera, Inc. Prenatal diagnostic resting standards
JP6534191B2 (ja) * 2013-10-21 2019-06-26 ベリナタ ヘルス インコーポレイテッド コピー数変動を決定することにおける検出の感度を向上させるための方法
CN111534580B (zh) 2013-12-28 2024-06-04 夸登特健康公司 用于检测遗传变异的方法和系统
WO2015184404A1 (en) * 2014-05-30 2015-12-03 Verinata Health, Inc. Detecting fetal sub-chromosomal aneuploidies and copy number variations
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
DK3230469T3 (da) * 2014-12-12 2019-07-15 Verinata Health Inc Anvendelse af cellefri DNA-fragmentstørrelse til bestemmelse af kopiantalsvariationer
US10453556B2 (en) * 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
JP6991134B2 (ja) * 2015-10-09 2022-01-12 ガーダント ヘルス， インコーポレイテッド 無細胞ｄｎａを使用する集団ベースの処置レコメンダ
SG11201805119QA (en) * 2015-12-17 2018-07-30 Guardant Health Inc Methods to determine tumor gene copy number by analysis of cell-free dna
US9850523B1 (en) * 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
EP3792922A1 (en) * 2016-09-30 2021-03-17 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
IL302912A (en) * 2016-12-22 2023-07-01 Guardant Health Inc Methods and systems for analyzing nucleic acid molecules

Also Published As

Publication number Publication date
KR102610098B1 (ko) 2023-12-04
CA3030038A1 (en) 2018-01-11
EP3481966B1 (en) 2023-11-08
JP2019531700A (ja) 2019-11-07
EP4322168A2 (en) 2024-02-14
AU2017292854A1 (en) 2019-01-24
JP2024119898A (ja) 2024-09-03
KR20190026837A (ko) 2019-03-13
EP4322168A3 (en) 2024-05-15
EP3481966A4 (en) 2019-08-07
JP7448310B2 (ja) 2024-03-12
AU2017292854B2 (en) 2023-08-17
WO2018009723A1 (en) 2018-01-11
CN109689891A (zh) 2019-04-26
CN109689891B (zh) 2024-06-18
US20260204345A9 (en) 2026-07-16
JP2022025101A (ja) 2022-02-09
SG11201811556RA (en) 2019-01-30
MX2019000037A (es) 2019-07-10
BR112019000296A2 (pt) 2019-04-16
EP3481966A1 (en) 2019-05-15
US20190287645A1 (en) 2019-09-19

Similar Documents

Publication Publication Date Title
AU2017292854B2 (en) Methods for fragmentome profiling of cell-free nucleic acids
US12590326B2 (en) Methods for fragmentome profiling of cell-free nucleic acids
ES2989374T3 (es) Sistemas y procedimientos para predecir el estado de deficiencia de recombinación homóloga de una muestra
Hardiman et al. Intra-tumor genetic heterogeneity in rectal cancer
ES2687847T3 (es) Análisis mutacional de ADN de plasma para la detección de cáncer
CN111278993B (zh) 从无细胞核酸中检测体细胞单核苷酸变体并应用于微小残留病变监测
ES2923602T3 (es) Detección y tratamiento de enfermedades que muestran heterogeneidad celular de enfermedad y sistemas y métodos para comunicar los resultados de las pruebas
ES2911613T3 (es) Análisis de patrones de metilación de haplotipos en tejidos en una mezcla de ADN
Alkodsi et al. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data
JP2022028907A (ja) がんの進化の検出および診断
ES2989622T3 (es) Uso de anomalías de tamaño y número en el ADN plasmático para detectar un cáncer
Zhang et al. The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers
Rosolowski et al. Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas
HK40008790B (en) Methods for fragmentome profiling of cell-free nucleic acids
HK40008790A (en) Methods for fragmentome profiling of cell-free nucleic acids
Kwon et al. A Predictive Model for Distant Metastasis in Patients With Breast Cancer Based on Machine Learning
HK40056499A (en) Mutational analysis of plasma dna for cancer detection
HK40082326A (en) Methylation pattern analysis of haplotypes in tissues in dna mixture
JP2024533359A (ja) がん診断及び治療処置選択を改善するための次世代シークエンシング及び人工知能に基づくアプローチ
HK1246830B (en) Mutational analysis of plasma dna for cancer detection
Chi Recurrent copy number alteration analysis identifies risk genes in young women with breast cancer
HK1205533B (en) Mutational analysis of plasma dna for cancer detection